Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis

This was a post-hoc analysis of patient-reported outcomes from the LIBERTY AD PEDS randomized, double-blind, placebo-controlled, phase III trial of dupilumab + topical corticosteroids (TCS) in 367 children aged 6–11 years with severe atopic dermatitis (AD). At week 16, significantly more patients tr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of dermatology (1951) 2023-07, Vol.189 (2), p.238-240
Hauptverfasser:	Flohr, Carsten, Irvine, Alan D, Cork, Michael J, Simpson, Eric L, Wollenberg, Andreas, Deleuran, Mette, Praestgaard, Amy, Thomas, Ryan B, Rossi, Ana B
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!